Arnogene: A Phosphocalcic Study in Dialysis (ARNOGENE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00858260
Recruitment Status : Completed
First Posted : March 9, 2009
Last Update Posted : September 4, 2009
Information provided by:
Hospices Civils de Lyon

March 6, 2009
March 9, 2009
September 4, 2009
November 2008
Not Provided
Assessing morbi-mortality based on Klotho variants
Same as current
Complete list of historical versions of study NCT00858260 on Archive Site
Survival and serum phosphocalcic parameters
Same as current
Not Provided
Not Provided
Arnogene: A Phosphocalcic Study in Dialysis
Genetic Determinants of Phosphocalcic Metabolism in Hemodialysis Patients
Searching for high morbi-mortality risk Klotho variants in dialysis patients
Not Provided
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Searching for high morbi-mortality risk Klotho variants
Non-Probability Sample
Adult patients undergoing maintenance dialysis since at leat three months
Genetic: blood sample
Searching for Klotho variants in DNA
hemodialysis patients
Adult patients undergoing maintenance dialysis since at leat three months
Intervention: Genetic: blood sample
Marçais C, Maucort-Boulch D, Drai J, Dantony E, Carlier MC, Blond E, Genet L, Kuentz F, Lataillade D, Legrand E, Moreau-Gaudry X, Jean G, Fouque D; ARNOGENE Project. Circulating Klotho Associates With Cardiovascular Morbidity and Mortality During Hemodialysis. J Clin Endocrinol Metab. 2017 Sep 1;102(9):3154-3161. doi: 10.1210/jc.2017-00104.

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Same as current
February 2009
Not Provided

Inclusion Criteria:

  • Every adult > 18 years old and treated by dialysis in centers located in the Rhone Alpes area in France.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Pr Denis FOUQUE, Hospices Civils de Lyon
Hospices Civils de Lyon
Not Provided
Principal Investigator: FOUQUE Denis, MD Hospices Civils de Lyon
Principal Investigator: LEGRAND Eric, MD CH Annonay
Principal Investigator: KAARASLAN Huseyin, MD CH Bourgoin Jallieu
Principal Investigator: ABOKASEM Ayman, MD CH Chalon/saône
Principal Investigator: LATAILLADE Claire Dominique, MD CH Sallanches
Principal Investigator: KUENTZ François, MD Centre Dialyse eaux claires
Principal Investigator: HACHACHE Toufic, MD CHU Grenoble - La Tronche
Principal Investigator: LEITIENNE Philippe, MD Hospices Civils de Lyon
Principal Investigator: ARKOUCHE Walid, MD AURAL - Lyon
Principal Investigator: HEYANI Ahmed, MD CH MACON
Principal Investigator: HANNOUN Jacques, MD CH Villefranche/saône
Principal Investigator: COMBARNOUS François, MD Clinique du Tonkin VILLEURBANNE
Principal Investigator: MAUREAUGANDRY Xavier, MD AGDUC - Montélimar
Principal Investigator: SIRAJEDINE Mohamed, MD CH ROMANS/ISERE
Principal Investigator: JEAN Ahmed, MD Centre du Rein - Tassin la demi lune
Principal Investigator: DENICOLA Cora, MD Calydial - CH Viennes
Hospices Civils de Lyon
September 2009